Meeting
Abstract Number: 269
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: The use of IV insulin is one of the primary therapeutic options for the treatment of hyperkalemia. Unfortunately the available literature reports that hypoglycemia is a common occurrence as a result of the treatment of hyperkalemia. During our safety event review process, we identified the same issue within our own institution. Due to reports […]
Abstract Number: 721
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: A 56-year-old man with history of hypertension on amlodipine, hydralazine, losartan, spironolactone, and torsemide, uncontrolled insulin dependent type 2 diabetes mellitus, chronic kidney disease (CKD) stage IIIb, and chronic lymphocytic leukemia (CLL) with extreme leukocytosis of 268,600/uL on admission presented to the hospital for progressive shortness of breath and was found to be […]